What is CVE-2023-26969?

CVE-2023-26969 is a high-severity vulnerability in Atrocore Atropim, classified under Path Traversal. CVSS score: 7.5/10. Published 2023-04-14.

How severe is CVE-2023-26969?

High severity. CVSS v3 base score is 7.5 out of 10.

Path Traversal in Atrocore Atropim

CVE-2023-26969

Atropim 1.5.26 is vulnerable to Directory Traversal.

Vulnerability class: Path Traversal (Directory Traversal)

Published 2023-04-14 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N.

EPSS exploit prediction

EPSS: 0.011 (63.4th percentile), scored 2026-10-02.

Low probability of exploitation in the next 30 days, but still tracked. 63rd percentile — 63.4% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.011 · newest: 0.011 · change: 0.000

Affected products

Atrocore Atropim — versions 1.5.26

Weakness classification (CWE)

CWE-22 — Path Traversal

References

github.com/nu11secur1ty/CVE-nu11secur1ty/tree/main/vendors/atrocore/atrocore-1… (Exploit, Third Party Advisory)

Frequently asked questions

What is CVE-2023-26969?: CVE-2023-26969 is a high-severity vulnerability in Atrocore Atropim, classified under Path Traversal. CVSS score: 7.5/10. Published 2023-04-14.
How severe is CVE-2023-26969?: High severity. CVSS v3 base score is 7.5 out of 10.